Robert A. Baiocchi

14.1k citations

229 papers · 6.3k indexed · 1 hit paper · h-index 42

Impact in

Immunology top 1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Oncology top 1%
- Viral-associated cancers and disorders
- CAR-T cell therapy research

Papers in

Pathology and Forensic Medicine 110
- Lymphoma Diagnosis and Treatment 104
Genetics 46
- Chronic Lymphocytic Leukemia Research 42

Co-authors: Michael A. Caligiuri Saı̈d Sif Pierluigi Porcu Lapo Alinari William E. Carson Vrajesh Karkhanis M. A. Caligiuri John C. Byrd
Journals: Blood (66 papers)Journal of Clinical Oncology (7 papers)Clinical Cancer Research (6 papers)JCI Insight (5 papers)Blood Advances (5 papers)
Partner nations: United States Italy Qatar

In The Last Decade

Robert A. Baiocchi

210 papers receiving 6.2k citations

Hit Papers

align trajectories log scale

The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody 2010 · 660 citations

Peers

Countries citing papers authored by Robert A. Baiocchi

Since Specialization

Citations

This map shows the geographic impact of Robert A. Baiocchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Baiocchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Baiocchi more than expected).

Fields of papers citing papers by Robert A. Baiocchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Baiocchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Baiocchi. The network helps show where Robert A. Baiocchi may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert A. Baiocchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert A. Baiocchi Line = papers co-authored together Robert A. Baiocchi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Updated Clinical Results: A Multicenter, Open-Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Recipients with Epstein–Barr Virus–Driven Posttransplant Lymphoproliferative Disease after Failure of Rituximab or Rituximab Plus Chemotherapy Transplantation and Cellular Therapy ·Armin Ghobadi, Robert A. Baiocchi, Prof. Amer Beitinjaneh, Sridhar Chaganti, Sylvain Choquet, Daan Derickx, Rajani Dinavahi, Xinyuan Duan, Laurence Gamelin, Kris M. Mahadeo, Aditi Mehta, Sarah Nikiforow, Ran Reshef, Sandrine Roye, Jean-Claude Vedovato, Susan E. Prockop	2025	0
2	Malignancy-Induced Functional Tricuspid Obstruction Complicated by Cardiopulmonary Collapse Treated Using Combination VA-ECMO and AngioVac JACC Case Reports ·Hafez Golzarian, Anna Kleman, Mallory Knous, J. Matthew Fields, D.E. Pitts, Andria Utendorf, Amanda Laird, Aakash Kumar, William C. Cole, Robert A. Baiocchi, Sandeep M. Patel	2025	0
3	Targeting PRMT5 in Primary Hemophagocytic Lymphohistiocytosis: A Novel Therapeutic Approach Using a Perforin-Deficient Mouse Model Blood ·Sheldon Steyn, Chia-Jo Chen, Rachel Saadey, Charlene Mao, Peggy Scherle, Neha Bhagwat, Kris Vaddi, Eric Brooks, Robert A. Baiocchi, Michael B. Jordan, Polina Shindiapina	2024	0
4	Is it time to reduce the length of postgraduate training for physician-scientists in internal medicine? JCI Insight ·Emily J. Gallagher, Paul R. Conlin, Barbara I. Kazmierczak, Jatin M. Vyas, Olujimi A. Ajijola, Christopher D. Kontos, Robert A. Baiocchi, Kyu Y. Rhee, Patrick J Hu, Carlos M. Isales, Christopher S. Williams, Don C. Rockey	2024	4
5	Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087) Clinical Cancer Research ·Missak Haigentz, Jeannette Y. Lee, Elizabeth Y. Chiao, David M. Aboulafia, Lee Ratner, Richard F. Ambinder, Robert A. Baiocchi, Ronald T. Mitsuyasu, William Wachsman, Joseph A. Sparano, Michelle A. Rudek	2023	3
6	The Burden of Epstein–Barr Virus (EBV) and Its Determinants among Adult HIV-Positive Individuals in Ethiopia Viruses ·Kidist Zealiyas, Seifegebriel Teshome, Nega Berhe, Wondwossen Amogne, Aklilu Feleke Haile, Ebba Abate, Getnet Yimer, Christoph Weigel, Elshafa H. Ahmed, Tamrat Abebe, Robert A. Baiocchi	2023	5
7	Zanubrutinib in Combination with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): Interim Results from a Phase 1b Clinical Trial Blood ·Yazeed Sawalha, Rina Li Welkie, Anna Krivenko, Brian Hess, Audrey M. Sigmund, Timothy Voorhees, Walter Hanel, David A. Bond, John Reneau, Narendranath Epperla, Lapo Alinari, Jonathan E. Brammer, Beth Christian, Robert A. Baiocchi, Kami J. Maddocks	2023	0
8	Detection and Quantification of the Epstein-Barr Virus in Lymphoma Patients from Ethiopia: Molecular and Serological Approaches Microorganisms ·Seifegebriel Teshome, Kidist Zealiyas, Abdulaziz Abubeker, Fisihatsion Tadesse, Jayalakshmi Balakrishna, Christoph Weigel, Tamrat Abebe, Elshafa H. Ahmed, Robert A. Baiocchi	2023	1
9	Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study Cancer ·Lakshmi Rajdev, Chia-Ching J. Wang, Himanshu Joshi, Shelly Lensing, Jeannette Y. Lee, Juan Carlos Ramos, Robert A. Baiocchi, Lee Ratner, P Rubinstein, Richard F. Ambinder, David H. Henry, Howard Streicher, Richard F. Little, Elizabeth Y. Chiao, Dirk P. Dittmer, Mark H. Einstein, Ethel Cesarman, Ronald T. Mitsuyasu, Joseph A. Sparano	2023	6
10	Genotypes Distribution of Epstein–Barr Virus among Lymphoma Patients in Ethiopia International Journal of Molecular Sciences ·Seifegebriel Teshome, Elshafa H. Ahmed, Kidist Zealiyas, Abdulaziz Abubeker, Fisihatsion Tadesse, Christoph Weigel, Robert A. Baiocchi, Tamrat Abebe	2023	1
11	AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma Clinical Cancer Research ·Erin Reid, Kelly A. Shimabukuro, Page C. Moore, Richard F. Ambinder, Jack D. Bui, Semi Han, Otoniel Martı́nez-Maza, Dirk P. Dittmer, David M. Aboulafia, Elizabeth Y. Chiao, Toby Maurer, Robert A. Baiocchi, Ronald T. Mitsuyasu, William Wachsman	2022	12
12	Pearls of wisdom for aspiring physician-scientist residency applicants and program directors JCI Insight ·Emily J. Gallagher, Don C. Rockey, Christopher D. Kontos, Jatin M. Vyas, Lawrence F. Brass, Patrick J Hu, Carlos M. Isales, Olujimi A. Ajijola, W. Kimryn Rathmell, Paul R. Conlin, Robert A. Baiocchi, Barbara I. Kazmierczak, Myles H. Akabas, Christopher S. Williams	2022	5
13	PRMT5 regulates T cell interferon response and is a target for acute graft-versus-host disease JCI Insight ·Katiri Snyder, Nina C. Zitzer, Yandi Gao, Hannah Choe, Natalie E. Sell, Lotus Neidemire-Colley, Anora Ignaci, Charuta Kale, Raymond D. Devine, Maria G. Abad, Maciej Pietrzak, Min Wang, Hong Lin, Yang W. Zhang, Gregory K. Behbehani, Jane E. Jackman, Ramiro Garzon, Kris Vaddi, Robert A. Baiocchi, Parvathi Ranganathan	2020	27
14	Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial) Blood ·Juan Carlos Ramos, Joseph A. Sparano, Amy Chadburn, Erin Reid, Richard F. Ambinder, Eric R. Siegel, Page C. Moore, P Rubinstein, Christine M. Durand, Ethel Cesarman, David M. Aboulafia, Robert A. Baiocchi, Lee Ratner, Lawrence Kaplan, Adam A. Capoferri, Jeannette Y. Lee, Ronald T. Mitsuyasu, Ariela Noy	2020	36
15	Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone Clinical Cancer Research ·James P. Dugan, Bradley M. Haverkos, Lynda Villagomez, Ludmila Katherine Martin, Mark Lustberg, John T. Patton, Marisa F. Martin, Ying Huang, Gerard J. Nuovo, Fengting Yan, Robert Cavaliere, Joyce D. Fingeroth, Shannon C. Kenney, Richard F. Ambinder, Gerard Lozanski, Pierluigi Porcu, Michael A. Caligiuri, Robert A. Baiocchi	2018	16
16	Efficacy and Safety of ATA129, Partially Matched Allogeneic Third-Party Epstein-Barr Virus-Targeted Cytotoxic T Lymphocytes in a Multicenter Study for Post-Transplant Lymphoproliferative Disorder Biology of Blood and Marrow Transplantation ·Susan E. Prockop, Ai Li, Robert A. Baiocchi, Nancy Bunin, Kris M. Mahadeo, Eneida R. Nemecek, Sarah Nikiforow, Ran Reshef, Donald E. Tsai, Willis H. Navarro, Richard J. O’Reilly	2018	6
17	Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma Molecular Cancer Therapeutics ·Andrew Stiff, Enrico Caserta, Douglas W. Sborov, Gerard J. Nuovo, Xiaokui Mo, Sarah Schlotter, Alessandro Canella, Emily Smith, Joseph Badway, Matthew Old, Alena Cristina Jaime‐Ramirez, Pearlly S. Yan, Don M. Benson, John C. Byrd, Robert A. Baiocchi, Balveen Kaur, Craig C. Hofmeister, Flavia Pichiorri	2016	31
18	The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody Blood ·Don M. Benson, Courtney E. Bakan, Anjali Mishra, Craig C. Hofmeister, Yvonne A. Efebera, Brian Becknell, Robert A. Baiocchi, Jianying Zhang, Jianhua Yu, Megan Smith, Carli N Greenfield, Pierluigi Porcu, Steven M. Devine, Rinat Rotem‐Yehudar, Gerard Lozanski, John C. Byrd, Michael A. Caligiuri Hit paper breakdown →	2010	660
19	GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder Journal of Clinical Investigation ·Robert A. Baiocchi, Jacqueline S. Ward, Lester Carrodeguas, Charles F. Eisenbeis, Ruoqi Peng, Sameek Roychowdhury, Srinivas Vourganti, Taryn Sekula, Maggie O’Brien, Melvin L. Moeschberger, Michael A. Caligiuri	2001	39
20	Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies. Journal of Clinical Investigation ·Vijay P. Khatri, Todd A. Fehniger, Robert A. Baiocchi, Feng Yu, Manisha H. Shah, D S Schiller, M. Gould, Ricardo T. Gazzinelli, Zale P. Bernstein, Michael A. Caligiuri	1998	50

About Robert A. Baiocchi

Robert A. Baiocchi is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Immunology and Hematology, having authored 229 papers that have together received 6.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (104 papers), Viral-associated cancers and disorders (79 papers), Cancer-related gene regulation (46 papers), Chronic Lymphocytic Leukemia Research (42 papers), Immune Cell Function and Interaction (31 papers), Epigenetics and DNA Methylation (18 papers), CNS Lymphoma Diagnosis and Treatment (17 papers) and CAR-T cell therapy research (16 papers). The work is most often cited by research in Immunology (2.4k citations), Oncology (2.2k citations), Pathology and Forensic Medicine (1.3k citations), Genetics (563 citations) and Hematology (576 citations). Robert A. Baiocchi has collaborated with scholars based in United States, Italy and Qatar. Frequent co-authors include Michael A. Caligiuri, Saı̈d Sif, Pierluigi Porcu, Lapo Alinari, William E. Carson, Vrajesh Karkhanis, M. A. Caligiuri, John C. Byrd, Michael R. Grever and Brian Becknell. Their work appears in journals such as Blood, Journal of Clinical Oncology, Clinical Cancer Research, JCI Insight and Blood Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact